rs2267715
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001883.5(CRHR2):c.229+5444C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.482 in 151,900 control chromosomes in the GnomAD database, including 20,419 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.48 ( 20419 hom., cov: 31)
Consequence
CRHR2
NM_001883.5 intron
NM_001883.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.610
Publications
19 publications found
Genes affected
CRHR2 (HGNC:2358): (corticotropin releasing hormone receptor 2) The protein encoded by this gene belongs to the G-protein coupled receptor 2 family, and the subfamily of corticotropin releasing hormone receptor. This receptor shows high affinity for corticotropin releasing hormone (CRH), and also binds CRH-related peptides such as urocortin. CRH is synthesized in the hypothalamus, and plays an important role in coordinating the endocrine, autonomic, and behavioral responses to stress and immune challenge. Studies in mice suggest that this receptor maybe involved in mediating cardiovascular homeostasis. Alternatively spliced transcript variants encoding different isoforms have been described for this gene.[provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.621 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CRHR2 | NM_001883.5 | c.229+5444C>T | intron_variant | Intron 2 of 11 | ENST00000471646.6 | NP_001874.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.483 AC: 73280AN: 151782Hom.: 20419 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
73280
AN:
151782
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.482 AC: 73285AN: 151900Hom.: 20419 Cov.: 31 AF XY: 0.480 AC XY: 35608AN XY: 74230 show subpopulations
GnomAD4 genome
AF:
AC:
73285
AN:
151900
Hom.:
Cov.:
31
AF XY:
AC XY:
35608
AN XY:
74230
show subpopulations
African (AFR)
AF:
AC:
7708
AN:
41408
American (AMR)
AF:
AC:
8268
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
2443
AN:
3468
East Asian (EAS)
AF:
AC:
2288
AN:
5140
South Asian (SAS)
AF:
AC:
2182
AN:
4810
European-Finnish (FIN)
AF:
AC:
6111
AN:
10550
Middle Eastern (MID)
AF:
AC:
172
AN:
292
European-Non Finnish (NFE)
AF:
AC:
42492
AN:
67928
Other (OTH)
AF:
AC:
1116
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1707
3414
5120
6827
8534
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
650
1300
1950
2600
3250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1442
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.